These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 8480491)
21. A comparison of intravenous immunoglobulin (2 g/kg totally) and single doses of anti-D immunoglobulin at 50 μg/kg, 75 μg/kg in newly diagnosed children with idiopathic thrombocytopenic purpura: Ankara hospital experience. Alioglu B; Ercan S; Tapci AE; Zengin T; Yazarli E; Dallar Y Blood Coagul Fibrinolysis; 2013 Jul; 24(5):505-9. PubMed ID: 23470649 [TBL] [Abstract][Full Text] [Related]
22. Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura. Ay Y; Karapinar TH; Oymak Y; Toret E; Demirag B; Ince D; Ozcan E; Moueminoglou N; Koker SA; Vergin C Blood Coagul Fibrinolysis; 2016 Jun; 27(4):431-5. PubMed ID: 26656905 [TBL] [Abstract][Full Text] [Related]
23. Clinical course of children with immune thrombocytopenic purpura treated with intravenous immunoglobulin G or megadose methylprednisolone or observed without therapy. Duru F; Fisgin T; Yarali N; Kara A Pediatr Hematol Oncol; 2002 Jun; 19(4):219-25. PubMed ID: 12051587 [TBL] [Abstract][Full Text] [Related]
24. The effect of steroid and intravenous immunoglobulin on thrombopoietin levels in pediatric patients with immune thrombocytopenic purpura. Koçak U; Gürsel T; Oztürk G Blood Coagul Fibrinolysis; 2000 Mar; 11(2):121-5. PubMed ID: 10759004 [TBL] [Abstract][Full Text] [Related]
25. The efficacy of different dose intravenous immunoglobulin in treating acute idiopathic thrombocytopenic purpura: a meta-analysis of 13 randomized controlled trials. Qin YH; Zhou TB; Su LN; Lei FY; Zhao YJ; Huang WF Blood Coagul Fibrinolysis; 2010 Dec; 21(8):713-21. PubMed ID: 20962624 [TBL] [Abstract][Full Text] [Related]
27. Retrospective evaluation of children with immune thrombocytopenic purpura and factors contributing to chronicity. Güngör T; Arman Bilir Ö; Koşan Çulha V; Güngör A; Kara A; Azık FM; Yaralı HN Pediatr Neonatol; 2019 Aug; 60(4):411-416. PubMed ID: 30470618 [TBL] [Abstract][Full Text] [Related]
28. Intravenous immune globulin versus intravenous anti-D immune globulin for the treatment of acute immune thrombocytopenic purpura. Shahgholi E; Vosough P; Sotoudeh K; Arjomandi K; Ansari S; Salehi S; Faranoush M; Ehsani MA Indian J Pediatr; 2008 Dec; 75(12):1231-5. PubMed ID: 19190878 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of clinical characteristics, diagnosis and management in childhood immune thrombocytopenic purpura: a single center's experience. Koçak U; Aral YZ; Kaya Z; Oztürk G; Gürsel T Turk J Pediatr; 2007; 49(3):250-5. PubMed ID: 17990576 [TBL] [Abstract][Full Text] [Related]
30. Low-dose versus high-dose immunoglobulin for primary treatment of acute immune thrombocytopenic purpura in children: results of a prospective, randomized single-center trial. Benesch M; Kerbl R; Lackner H; Berghold A; Schwinger W; Triebl-Roth K; Urban C J Pediatr Hematol Oncol; 2003 Oct; 25(10):797-800. PubMed ID: 14528103 [TBL] [Abstract][Full Text] [Related]
31. Splenectomy for idiopathic thrombocytopenic purpura: a five-year retrospective review. Gibson M; Sehon JK; White S; Zibari GB; Johnson LW Am Surg; 2000 Oct; 66(10):952-4; discussion 955. PubMed ID: 11261623 [TBL] [Abstract][Full Text] [Related]
32. Treatment, outcome, and cost of care in children with idiopathic thrombocytopenic purpura. Kumar M; Vik TA; Johnson CS; Southwood ME; Croop JM Am J Hematol; 2005 Mar; 78(3):181-7. PubMed ID: 15726607 [TBL] [Abstract][Full Text] [Related]
33. Combination therapy for refractory idiopathic thrombocytopenic purpura in adolescents. Williams JA; Boxer LA J Pediatr Hematol Oncol; 2003 Mar; 25(3):232-5. PubMed ID: 12621242 [TBL] [Abstract][Full Text] [Related]
34. Clinical features, treatment responses, and outcome of children with idiopathic thrombocytopenic purpura. Demircioğlu F; Saygi M; Yilmaz S; Oren H; Irken G Pediatr Hematol Oncol; 2009; 26(7):526-32. PubMed ID: 19863209 [TBL] [Abstract][Full Text] [Related]
37. [Treatment of immune thrombocytopenic purpura in Pediatrics. Therapeutic efficacy of a regional intravenous immunoglobulin G]. Buteler C; Colombo H; Gabosi G; Manfredi MJ; Montero S; Pasquali MA; Rougier C; Sisti AM Medicina (B Aires); 2001; 61(5 Pt 1):522-8. PubMed ID: 11721317 [TBL] [Abstract][Full Text] [Related]
38. Response to high-dose intravenous immune globulin as a valuable factor predicting the effect of splenectomy in chronic idiopathic thrombocytopenic purpura patients. Choi CW; Kim BS; Seo JH; Shin SW; Kim YH; Kim JS; Sohn SK; Kim JS; Shin DG; Ryoo HM; Lee KH; Lee JJ; Chung IJ; Kim HJ; Kwak JY; Yim CY; Ahn JS; Lee JA; Park YS Am J Hematol; 2001 Mar; 66(3):197-202. PubMed ID: 11279626 [TBL] [Abstract][Full Text] [Related]